지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2021.1
- 수록면
- 536 - 543 (8page)
이용수
초록· 키워드
오류제보하기
Glucocorticoids are used to treat many autoimmune and inflammatory diseases. However, an adverse systemic effect is a deleterious effect on bone, which may lead to glucocorticoid-induced osteoporosis, characterized by a rapid and transient increase in bone resorption and fracture risk, which may increase rapidly within 3 months of commencing oral glucocorticoids. Therefore, early risk assessment and intervention are crucial for preventing fractures in patients receiving glucocorticoids. Recent practice guidelines recommend an assessment for fracture risk in patients beginning or receiving glucocorticoids for more than 3 months, and they have suggested fracture risk assessment tool values for identifying patients who need preventive treatment. Bisphosphonates are currently the recommended first-line therapy for the prevention and treatment of glucocorticoid-induced osteoporosis. These have been shown to increase the bone mineral density in the spine and hip and to decrease the incidence of vertebral fractures. Recently, a more potent antiresorptive agent, denosumab, has been shown to increase the bone density in patients receiving glucocorticoids. Teriparatide has been shown to have a preventive effect on vertebral fractures, but not on nonvertebral fractures. In this article we aimed to providean update on glucocorticoid-induced osteoporosis by focusing on the assessment of its risk and treatment options.
목차
등록된 정보가 없습니다.
참고문헌 (60)
참고문헌 신청
Hench P / 1950 / Effects of cortisone in the rheumatic diseases / Lancet 2:483~484
Lane NE / 1998 / The science and therapy of glucocorticoid-induced bone loss / Endocrinol Metab Clin North Am 27:465~483
Overman RA / 2013 / Prevalence of oral glucocorticoid usage in the United States: a general population perspective / Arthritis Care Res(Hoboken) 65:294~298
Fardet L / 2011 / Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20years / Rheumatology(Oxford) 50:1982~1990
Gudbjornsson B / 2002 / Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice / Ann Rheum Dis 61:32~36
Lane NE / 1998 / The science and therapy of glucocorticoid-induced bone loss / Endocrinol Metab Clin North Am 27:465~483
Overman RA / 2013 / Prevalence of oral glucocorticoid usage in the United States: a general population perspective / Arthritis Care Res(Hoboken) 65:294~298
Fardet L / 2011 / Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20years / Rheumatology(Oxford) 50:1982~1990
Gudbjornsson B / 2002 / Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice / Ann Rheum Dis 61:32~36
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Management of glucocorticoid-related osteoporotic vertebral fracture
Osteoporosis and Sarcopenia
2020 .01
-
The effect of glucocorticoids on bone and muscle
Osteoporosis and Sarcopenia
2015 .01
-
스테로이드 유발성 골다공증
대한내과학회지
2017 .01
-
Association between perioperative glucocorticoids and cancer metastasis and survival in patients undergoing radical cystectomy for urothelial carcinoma of the bladder: A single-center retrospective study
Investigative and Clinical Urology
2020 .01
-
Glucocorticoids as a Double-Edged Sword in the Treatment of COVID-19: Mortality and Severity of COVID-19 in Patients Receiving Long-Term Glucocorticoid Therapy
Endocrinology and Metabolism
2023 .04
-
Perioperative glucocorticoid management based on current evidence
Anesthesia and Pain Medicine
2021 .01
-
Korean Guideline for the Prevention and Treatment of Glucocorticoid-induced Osteoporosis
대한골대사학회지
2018 .01
-
Glucocorticoid-Induced Hyperglycemia: A Neglected Problem
Endocrinology and Metabolism
2024 .04
-
Risk Factors of Osteoporosis in Rheumatoid Arthritis Patients; Glucocorticoid, Inactivity, or Nutrient Deficiencies
대한류마티스학회지
2017 .01
-
An update of the Malaysian Clinical Guidance on the management of glucocorticoid-induced osteoporosis, 2015
Osteoporosis and Sarcopenia
2017 .01
-
Fracture Risk and Its Prevention Patterns in Korean Patients with Polymyalgia Rheumatica: a Retrospective Cohort Study
Journal of Korean Medical Science
2021 .10
-
Factors Affecting Bone Mineral Density Measurement after Fracture in South Korea
대한골대사학회지
2017 .01
-
RANKL 억제제의 최신 업데이트
대한내과학회지
2018 .01
-
Environmental Air Pollution and the Risk of Osteoporosis and Bone Fractures
예방의학회지
2018 .01
-
Environmental Air Pollution and the Risk of Osteoporosis and Bone Fractures
예방의학회지
2018 .01
-
Comparison of bone mineral density and vertebral fracture assessment in postmenopausal women with and without distal radius fractures
Osteoporosis and Sarcopenia
2021 .12
-
Selective Activator of the Glucocorticoid Receptor Compound A Dissociates Therapeutic and Atrophogenic Effects of Glucocorticoid Receptor Signaling in Skin
대한암예방학회지
2015 .01
-
Operationalizing Treat-to-Target for Osteoporosis
Endocrinology and Metabolism
2021 .01
-
골다공증의 약물치료: 2022 update
대한의사협회지
2022 .04
-
Factors associated with osteoporosis medication initiation and adherence
Osteoporosis and Sarcopenia
2018 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0